Classified in: Business
Subject: INO

Thinking about buying stock in Ginkgo Bioworks Holdings, Ambrx Biopharma, Uranium Royalty Corp, Frontline Plc, or Femasys?

NEW YORK, Oct. 16, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DNA, AMAM, UROY, FRO, and FEMY.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

SOURCE InvestorsObserver

These press releases may also interest you

at 17:10	Retractable Technologies, Inc. Results for the Period Ended March 31, 2024
	Retractable Technologies, Inc. reports total net sales of $7.6 million for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the same period last year of $11.0 million and...
at 17:05	Americas Gold and Silver Reports Q1-2024 Results
	Americas Gold and Silver Corporation ("Americas" or the "Company"), a growing North American precious metals producer, reports consolidated financial and operational results for the quarter ended March 31, 2024. This earnings release should be...
at 17:05	Sable Offshore Corp. Reports First Quarter 2024 Financial Results and Provides Operational Updates
	Sable Offshore Corp. today announced its first quarter 2024 financial and operational results and near-term operational plans. First Quarter 2024 Financial Highlights Completed business combination with Flame Acquisition Corp (the "Business...
at 17:05	Amcomri Provides Further Bi-Weekly Default Status Report
	Amcomri Entertainment Inc. (the "Company") (Cboe CA: AMEN) is providing this further bi-weekly default status report in accordance with its obligations under National Policy 12-203 ? Management Cease Trade Orders ("NP 12-203"). As previously...
at 17:05	Extendicare Announces 2024 First Quarter Results
	Extendicare Inc. ("Extendicare" or the "Company") today reported results for the three months ended March 31, 2024. Results are presented in Canadian dollars unless otherwise noted. First Quarter 2024 Highlights Adjusted EBITDA(1) excluding...
at 17:05	Fidelity Investments Canada ULC announces fund mergers and terminations
	Fidelity Investments Canada ULC (Fidelity) today announced plans for the following mergers and terminations with an expected effective date of on or around September 6, 2024 (the "Effective Date"), subject to securityholder approval in certain cases....
	More news about Business...

News published on 16 october 2023 at 09:31 and distributed by:

Thinking about buying stock in Ginkgo Bioworks Holdings, Ambrx Biopharma, Uranium Royalty Corp, Frontline Plc, or Femasys?

These press releases may also interest you

Le Lézard

Others sections

Follow us